These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 35710431)

  • 21. SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination.
    Jarisch A; Wiercinska E; Daqiq-Mirdad S; Hellstern H; Ajib S; Cremer A; Nguyen NTT; Dukat A; Ullrich E; Ciesek S; Chow KU; Serve H; Seifried E; Bader P; Bonig H; Bug G
    Eur J Immunol; 2022 Jul; 52(7):1194-1197. PubMed ID: 35389515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future.
    Hall VG; Teh BW
    J Infect Dis; 2023 Aug; 228(Suppl 1):S55-S69. PubMed ID: 37539765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group.
    Piñana JL; López-Corral L; Martino R; Montoro J; Vazquez L; Pérez A; Martin-Martin G; Facal-Malvar A; Ferrer E; Pascual MJ; Sanz-Linares G; Gago B; Sanchez-Salinas A; Villalon L; Conesa-Garcia V; Olave MT; López-Jimenez J; Marcos-Corrales S; García-Blázquez M; Garcia-Gutiérrez V; Hernández-Rivas JÁ; Saus A; Espigado I; Alonso C; Hernani R; Solano C; Ferrer-Lores B; Guerreiro M; Ruiz-García M; Muñoz-Bellido JL; Navarro D; Cedillo A; Sureda A;
    Am J Hematol; 2022 Jan; 97(1):30-42. PubMed ID: 34695229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients With Pre-Cellular Therapy SARS-CoV-2 Infection.
    Nimgaonkar I; Yoke LH; Roychoudhury P; Flaherty PW; Oshima MU; Weixler A; Gauthier J; Greninger AL; Mielcarek M; Boeckh M; Liu C; Hill JA
    Clin Infect Dis; 2024 Jul; 79(1):86-95. PubMed ID: 38427848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Multiple SARS-CoV-2 Vaccine Doses in Patients with B Cell Hematologic Malignancies Receiving Chimeric Antigen Receptor T Cell Therapy: A Contemporary Cohort Analysis.
    Abid MB; Rubin M; Szabo A; Longo W; Fenske TS; McCoy C; Lorge A; Abedin S; D'Souza A; Dhakal B; Shah NN; Hamadani M
    Transplant Cell Ther; 2024 Mar; 30(3):285-297. PubMed ID: 38142942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience.
    Huguet M; Boigues M; Sorigué M; Blanco J; Quirant B; Ferrà C; ;
    Med Clin (Barc); 2024 Apr; 162(7):313-320. PubMed ID: 38000941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strong SARS-CoV-2 T-Cell Responses after One or Two COVID-19 Vaccine Boosters in Allogeneic Hematopoietic Stem Cell Recipients.
    Clémenceau B; Le Bourgeois A; Guillaume T; Coste-Burel M; Peterlin P; Garnier A; Jullien M; Ollier J; Grain A; Béné MC; Chevallier P
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robust spike-specific CD4
    Federico L; Tvedt THA; Gainullin M; Osen JR; Chaban V; Lund KP; Tietze L; Tran TT; Lund-Johansen F; Kared H; Lind A; Vaage JT; Stratford R; Tennøe S; Malone B; Clancy T; Myhre AEL; Gedde-Dahl T; Munthe LA
    Front Immunol; 2023; 14():1210899. PubMed ID: 37503339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy.
    Chen W; Ma Y; Shen Z; Chen H; Ma R; Yan D; Shi M; Wang X; Song X; Sun C; Cao J; Cheng H; Zhu F; Sun H; Li D; Li Z; Zheng J; Xu K; Sang W
    Front Immunol; 2021; 12():755549. PubMed ID: 34777367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of SARS-CoV-2 Vaccine Doses in Allogeneic Hemopoietic Stem Cell Recipients: A Systematic Review and Meta-Analysis.
    Rubin M; Suelzer E; Ulschmid C; Thapa B; Szabo A; Abid MB
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):393-399. PubMed ID: 38415523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.
    Madduri D; Parekh S; Campbell TB; Neumann F; Petrocca F; Jagannath S
    J Med Case Rep; 2021 Feb; 15(1):90. PubMed ID: 33608053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of transplant status in CD19-targeted CAR T-cell therapy: a systematic review and meta-analysis.
    Nagle K; Tafuto B; Palladino Kim L; Parrott JS
    Med Oncol; 2018 Sep; 35(11):144. PubMed ID: 30206753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101).
    Hill JA; Martens MJ; Young JH; Bhavsar K; Kou J; Chen M; Lee LW; Baluch A; Dhodapkar MV; Nakamura R; Peyton K; Howard DS; Ibrahim U; Shahid Z; Armistead P; Westervelt P; McCarty J; McGuirk J; Hamadani M; DeWolf S; Hosszu K; Sharon E; Spahn A; Toor AA; Waldvogel S; Greenberger LM; Auletta JJ; Horowitz MM; Riches ML; Perales MA
    medRxiv; 2024 Jan; ():. PubMed ID: 38343800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 vaccine response in CAR T-cell therapy recipients: A systematic review and preliminary observations.
    Abid MA; Abid MB
    Hematol Oncol; 2022 Apr; 40(2):287-291. PubMed ID: 34911142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis.
    Meejun T; Srisurapanont K; Manothummetha K; Thongkam A; Mejun N; Chuleerarux N; Sanguankeo A; Phongkhun K; Leksuwankun S; Thanakitcharu J; Lerttiendamrong B; Langsiri N; Torvorapanit P; Worasilchai N; Plongla R; Hirankarn N; Nematollahi S; Permpalung N; Moonla C; Kates OS
    Blood Adv; 2023 Sep; 7(18):5624-5636. PubMed ID: 37389818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipients.
    Sesques P; Bachy E; Ferrant E; Safar V; Gossez M; Morfin-Sherpa F; Venet F; Ader F
    Cancer Cell; 2022 Mar; 40(3):236-237. PubMed ID: 35093212
    [No Abstract]   [Full Text] [Related]  

  • 37. Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant Recipients.
    Lindemann M; Klisanin V; Thümmler L; Fisenkci N; Tsachakis-Mück N; Ditschkowski M; Schwarzkopf S; Klump H; Reinhardt HC; Horn PA; Koldehoff M
    Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is a third SARS-CoV-2 vaccine dose efficient in allogeneic haematopoietic cell transplant recipients?
    Spyridonidis A
    Br J Haematol; 2023 Apr; 201(1):9-10. PubMed ID: 36477621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients.
    Leclerc M; Redjoul R; Le Bouter A; Beckerich F; Robin C; Parinet V; Pautas C; Menouche D; Bouledroua S; Roy L; Cabanne L; Nait-Sidenas Y; Fourati S; Maury S
    J Hematol Oncol; 2022 Mar; 15(1):27. PubMed ID: 35303906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy.
    Chiuppesi F; Ortega-Francisco S; Gutierrez MA; Li J; Ly M; Faircloth K; Mack-Onyeike J; La Rosa C; Thomas S; Zhou Q; Drake J; Slape C; Fernando P; Rida W; Kaltcheva T; Grifoni A; Sette A; Patterson A; Dempsey S; Ball B; Ali H; Salhotra A; Stein A; Nathwani N; Rosenzweig M; Nikolaenko L; Al Malki MM; Dickter J; Nanayakkara DD; Puing A; Forman SJ; Taplitz RA; Zaia JA; Nakamura R; Wussow F; Diamond DJ; Dadwal SS
    Vaccines (Basel); 2023 Sep; 11(9):. PubMed ID: 37766168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.